Sexually transmitted diseases in older adults

Current Infectious Disease Reports

Volumn 8, Issue 2, 2006, Pages 139-147

  Wilson, Margaret Mary G ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; BUTOCONAZOLE; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOTRIMAZOLE; DOXYCYCLINE; FAMCICLOVIR; FLUCONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; MICONAZOLE; NYSTATIN; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN; TERCONAZOLE; VALACICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AGING; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REGIMEN; GENITAL HERPES; GENITAL ULCER; GERIATRIC PATIENT; GONOCOCCAL URETHRITIS; HAEMOPHILUS DUCREYI; HEALTH PRACTITIONER; HEMATOLOGIC DISEASE; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALIGNANT NEOPLASTIC DISEASE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA GONORRHOEAE; NEUROLOGIC DISEASE; NEUROSYPHILIS; OPPORTUNISTIC INFECTION; PATIENT CARE; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; QUALITY OF LIFE; REVIEW; SECONDARY SYPHILIS; SENSITIVITY AND SPECIFICITY; SEXUAL HEALTH; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SKIN DISEASE; SYPHILIS; TREPONEMA PALLIDUM; TRICHOMONIASIS; TUBERCULOSIS; ULCUS MOLLE; UNSPECIFIED SIDE EFFECT; UTERINE CERVICITIS; VAGINITIS; VARICELLA ZOSTER VIRUS;

EID: 33645307717     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-006-0010-z     Document Type: Review

References (57)

1. Carret ML, Fassa AG, da Silveira DS, et al.: [Sexually transmitted diseases symptoms in adults: prevalence and risk factors]. Rev Saude Publica 2004, 38:76-84.
2. Xu F, Schillinger JA, Aubin MR, et al.: Sexually transmitted diseases of older persons in Washington State. Sex Transm Dis 2001, 28:287-291.
3. Kalter DC, Rosen T: Sexually transmitted diseases. Emerg Med Clin North Am 1985, 3:693-716.
4. Diseker RA III, Peterman TA, Kamb ML, et al.: Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect 2000, 76:474-479.
5. Hogben M, Bloom F, McFarlane M, et al.: Factors associated with sexually transmitted disease clinic attendance. Int J Nurs Stud 2004, 41:911-920.
6. Reporting of chlamydial infection - Massachusetts, January-June 2003. MMWR Morb Mortal Wkly Rep 2005, 54:558-560.
7. LaMontagne DS, Fine DN, Marrazzo JM: Chlamydia trachomatis infection in asymptomatic men. Am J Prev Med 2003, 24:36-42.
8. Karlovsky M, Lebed B, Mydlo JH: Increasing incidence and importance of HIV/AIDS and gonorrhoea among men aged >/= 50 years in the US in the era of erectile dysfunction therapy. Scand J Urol Nephrol 2004, 38:247-252.
9. Mark KE, Gunn RA: Gonorrhoea surveillance: estimating epidemiologic and clinical characteristics of reported cases using a sample survey methodology. Sex Transm Dis 2004, 31:215-220.
10. McGrath C, Rene A, Jones B, Sandhu R: Descriptive study of sexually transmitted diseases in Tarrant County, Texas, from 1998 through 2000. Tex Med 2003, 99:48-53.
11. Spence MR: Gonorrhoea. Clin Obstet Gynecol 1983, 26:111-124.
12. Sanders JW, Hook EW III, Welsh LE, et al.: Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men. J Clin Microbiol 1994, 32:24-27.
13. Brackbill RM, Sternberg MR, Fishbein M: Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect 1999, 31:10-15.
14. Stamm WE, Hicks CB, Martin DH, et al.: Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA 1995, 274:545-549.
15. Schwebke JR, Burgess D: Trichomoniasis. Clin Microbiol Rev 2004, 17:794-803.
16. Soper D: Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 2004, 190:281-290.
17. Wendel KA: Trichomoniasis: What's New? Curr Infect Dis Rep 2003, 5:129-134.
18. Roy K, Wang SA, Meltzer MI: Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae. Emerg Infect Dis 2005, 11:1265-1273.
19. Ghanem KG, Giles JA, Zenilman JM: Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic. Infect Dis Clin North Am 2005, 19:351-365.
20. Wiesenfeld HC, Sweet RL, Ness RB, et al.: Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 2005, 32:400-405.
21. French L, Horton J, Matousek M: Abnormal vaginal discharge: what does and does not work in treating underlying causes. J Fam Pract 2004, 53:890-894.
22. Kissinger PJ, Dumestre J, Clark RA, et al.: Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis 2005, 32:227-230.
23. Swygard H, Miller WC, Kaydos-Daniels SC, et al.: Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis 2004, 31:659-664.
24. Price MA, Miller WC, Kaydos-Daniels SC, et al.: Trichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, Malawi. J Infect Dis 2004, 190:1448-1455.
25. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM: Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect 2003, 79:151-153.
26. Schwebke JR: Cost-effective screening for trichomoniasis. Emerg Infect Dis 2002, 8:749-750.
27. Schmid G, Narcisi E, Mosure D, et al.: Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001, 46:545-549.
28. Spiliopoulou A, Lakiotis V, Vittoraki A, et al.: Chlamydia trachomatis: time for screening? Clin Microbiol Infect 2005, 11:687-689.
29. Bhandari H, Malhotra S, Sharma M, Kumar B: Microbial flora of women with chronic cervicitis. J Indian Med Assoc 2000, 98:384-386.
30. Dybas I, Sidor-Wojtowicz A, Koziol-Montewka M: [Bacterial flora and mycosis of the vagina in women with symptoms of vaginal inflammation]. Ginekol Pol 2005, 76:385-390.
31. Chiaffarino F, Parazzini F, De BP, Lavezzari M: Risk factors for bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 2004, 117:222-226.
32. Gonzalez-Pedraza AA, Mota VR, Ortiz ZC, Ponce Rosas RE: [Factors of risk of bacterial vaginosis]. Aten Primaria 2004, 34:360-365.
33. Luni Y, Munim S, Qureshi R, Tareen AL: Frequency and diagnosis of bacterial vaginosis. J Coll Physicians Surg Pak 2005, 15:270-272.
34. Das S, Sabin C, Allan S: Higher vaginal pH is associated with Chlamydia trachomatis infection in women: a prospective case-controlled study. Int J STD AIDS 2005, 16:290-293.
35. Beigi RH, Austin MN, Meyn LA, et al.: Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004, 191:1124-1129.
36. Andreeva PM, Omar HA: Effectiveness of current therapy of bacterial vaginosis. Int J Adolesc Med Health 2002, 14:145-148.
37. Celum C, Levine R, Weaver M, Wald A: Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ 2004, 82:447-453.
38. Mertz KJ, Trees D, Levine WC, et al.: Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis 1998, 178:1795-1798.
39. Leone P: Reducing the risk of transmitting genital herpes: advances in understanding and therapy. Curr Med Res Opin 2005, 21:1577-1582.
40. Guirguis-Blake J, Wolff TA: Screening for genital herpes. Am Pam Physician 2005, 72:135-136.
41. Baldwin HE: STD update: screening and therapeutic options. Int J Fertil Womens Med 2001, 46:79-88.
42. Brown TJ, Yen-Moore A, Tyring SK: An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol 1999, 41:511-532.
43. Inelman EM, Gasparini C, Enzi C: HIV/AIDS in older adults: a case report and literature review. Geriatrics 2005, 60:26-30.
44. Kahn RH, Moseley KE, Thilges JN, et al.: Community-based screening and treatment for STDs: results from a mobile clinic initiative. Sex Transm Dis 2003, 30:654-658.
45. Caudie C, Garel F, Bancel J, et al.: [Diagnosis and biological monitoring of 6 neurosyphilis cases: value of cerebrospinal fluid analysis]. Ann Biol Clin (Paris) 2003, 61:563-569.
46. Polsky I, Samuels SC: Neurosyphilis. Screening does sometimes reveal an infectious cause of dementia. Geriatrics 2001, 56:60-62.
47. Augenbraun M: Treatment of latent and tertiary syphilis. Hosp Pract (Off Ed) 2000, 35:89-95.
48. Inelman EM, Gasparini G, Enzi G: HIV/AIDS in older adults: a case report and literature review. Geriatrics 2005, 60:26-30.
49. Wachter KW, Knodel JE, Vanlandingham M: AIDS and the elderly of Thailand: projecting familial impacts. Demography 2002, 39:25-41.
50. Kalichman SC, Heckman T, Kochman A: Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv 2000, 51:903-907.
51. Blacker J: The impact of AIDS on adult mortality: evidence from national and regional statistics. AIDS 2004, 18(Suppl 2):S19-S26.
52. Gaeta TJ, LaPolla C, Melendez E: AIDS in the elderly: New York City vital statistics. J Emerg Med 1996, 14:19-23.
53. Cury PM, Pulido CF, Furtado VM, da Palma FM: Autopsy findings in AIDS patients from a reference hospital in Brazil: analysis of 92 cases. Pathol Res Pract 2003, 199:811-814.
54. Babiker A, Darbyshire J, Pezzotti P, et al.: Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol 2002, 31:951-958.
55. Walsh K, Thompson W, Megyesi J, et al.: HIV-1/AIDS neuropathology in a Canadian teaching centre. Can J Neurol Sci 2004, 31:235-241.
56. Welch K, Morse A: The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy. AIDS Patient Care STDS 2002, 16:75-81.
57. Aceto L, Karrer U, Grube Ch, et al.: [Primary HIV-1 infection in Zurich: 2002-2004]. Schweiz Rundsch Me. Prax 2005, 94:1199-1205.